Abstract
Recent progress in behavioral neuroscience indicates that peripheral neural and endocrine feedback signals are crucial controls for the initiation, maintenance, and termination of meals, and, therefore, for total food intake and the maintenance of body weight (Campfield and Smith 1990; Scharrer and Langhans 1988; Smith and Gibbs 1992; Blundell 1991). I review here evidence that glucagon is one such signal. Results from tests of administration of glucagon or glucagon antagonists suggest that, under many conditions, glucagon released from the pancreas during meals acts in the liver to initiate a neural signal that is conveyed by vagal afferents to the brain, where it contributes to the termination of the meal.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berthoud H-R, Jeanrenaud B (1982) Sham feeding-induced cephalic phase insulin release in the rat. Am J Physiol 242: E280–E285
Berthoud H-R, Fox EA, Powley TL (1990) Localization of vagal preganglionics that stimulate insulin and glucagon secretion. Am J Physiol 258: R160–R168
Berthoud H-R, Carlson NR, Powley TL (1991) Topography of efferent vagal innervation of the rat gastrointestinal tract. Am J Physiol 260: R200–R207
Berthoud H-R, Kressel M, Neuhuber WL (1992) An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system. Anat Embryol 186: 431–442
Blackmore PF, Mojsov S, Exton JH, Habener JF (1991) Absence of insulinotropic glucagon-like peptide-1 (7–37) receptors on isolated rat liver hepatocytes. FEBS Lett 283: 7–10
Blundell JE (1991) Pharmacological approaches to appetite suppression. Trends Pharmacol Sci 12: 147–157
Braatvedt GD, Stanners A, Newrick PG, Halliwell M, Corrall RJM (1993) Evidence against a putative role for glucagon as a physiological splanchnic vasodilator in man. Clin Sci 84: 193–199
Brand CL, Rolin B, Jorgensen PN, Svendsen I, Kristensen JS, Holst JJ (1994) Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats. Diabetologia 37: 985–993
Campfield LA, Smith FJ (1990) Systemic factors in the control of food intake. In: Stricker EM (ed) Neurobiology of food and fluid intake. Plenum, New York, pp 183–206 (Handbook of behavioral neurobiology, vol 10)
Chiou GCY, Chuang CY (1988) Treatment of hypoglycemia with glucagon eye drops. J Ocular Pharm 4: 179–186
Clayton GW, Librik L (1963) Therapy of exogenous obesity in childhood and adolescence. Pediatr Clin North Am 10: 99–107
D’Almeida MS, Lautt WW (1991) Glucagon pharmacodynamics and modulation of sympathetic nerve and norepinephrine-induced constrictor responses in the superior mesenteric artery of the cat. J Pharmacol Exp Ther 259: 118–123
Day J, Johansen LK, Ganda OP, Soeldner JS, Gleason RE, Medgley W (1978) Factors governing insulin and glucagon response during normal meals. Clin Endocrinol (Oxf) 9: 443–454
DeCastro JM, Paullin SK, DeLugas GM (1978) Insulin and glucagon as determinants of body weight set point and microregulation in rats. J Comp Physiol Psychol 92: 571–579
Deetz LE, Wangsness PJ (1981) Influence of intrajugular administration of insulin, glucagon and propionate on voluntary feed intake of sheep. J Anim Sci 53: 427–433
DeJong A, Strubbe JH, Steffens AB (1977) Hypothalamic influence on insulin and glucagon release in the rat. Am J Physiol 233: E380–E388
Denker H, Hedner P, Holst J, Tranberg KG (1975) Pancreatic glucagon response to an ordinary meal. Scand J Gastroenterol 10: 471–474
Dinneen S, Alzaid A, Turk D, Rizza R (1995) Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia 38: 337–343
Dourish CT, Rycroft W, Iversen SD (1989) Postponement of satiety by blockade of brain cholecystokinin (CCK-8) receptors. Science 245: 1509–1511
Duss M (1986) Untersuchungen zur Sättingungswirkung von Glucagon. University of Zurich, Inaugural Dissertation. Maus, Konstanz
Foster D (1984) From glycogen to ketones — and back. Diabetes 33: 1188–1199
Friedman MI, Ketchum M, Ulrich P, Breslin PAS, DellaCorte C (1994) Evidence for innervation of the hepatic parenchyma in the rat. Soc Neurosci Abstr 20: 1226 (abstract)
Geary N (1987) Glucagon 1–21 fails to inhibit feeding. Peptides 8: 943–945
Geary N (1990) Pancreatic glucagon signals postprandial satiety. Neurosci Biobehav Rev 14: 323–338
Geary N (1995) A failure of pulsatile infusion to increase glucagon’s satiating potency. Physiol Behav 59: 613–616
Geary N, Smith GP (1982) Pancreatic glucagon fails to inhibit sham feeding in the rat. Peptides 3: 163–166
Geary N, Smith GP (1983) Selective hepatic vagotomy blocks pancreatic glucagon’s satiety effect. Physiol Behav 31: 391–394
Geary N, Farhoody N, Gersony A (1987) Food deprivation dissociates pancreatic glucagon’s effects on satiety and hepatic glucose production at dark onset. Physiol Behav 39: 507–511
Geary N, Kissileff HR, Pi-Sunyer FX, Hinton V (1992) Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men. Am J Physiol 262: R975–R980
Geary N, Le Sauter J, Noh N (1993) Glucagon acts in the liver to control spontaneous meal size in rats. Am J Physiol 264: R116–R122
Geary N, Asarian L, Langhans W (1995) Insulin does not increase glucagon’s potency to reduce meal size in spontaneously feeding rats. Soc Neurosci Abstr 21: 8 (abstract)
Gutniak M, Grill V, Efendic S (1986) Effect of composition of mixed meals—low- versus high-carbohydrate content — on insulin, glucagon, and somatostatin release in healthy humans and in patients with NIDDM. Diabetes Care 9 (3): 244–249
Hager J, Hansen L, Vaisse C, Vionnet N, Philippi A, Poller W, Velho G, Carcassi C, Contu L, Julier C, Cambien F, Passa P, Lathrop M, Kindsvogel W, Demenais F, Nishimura E, Froguel P (1995) A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nature Genet 9: 299–304
Hildebrandt W, Blech W, Kohnert K-D (1991a) Kinetic studies on hepatic handling of glucagon using the model of non-recirculating perfused rat livers. Horm Metab Res 23: 410–413
Hildebrandt W, Blech W, Kohnert K-D (1991b) Hepatische Reaktion auf pulsatile Anderungen der Pankreasglukagonkonzentration. Wiss Z Univ Halle 40: 137–149
Hildebrandt W, Blech W, Kohnert K-D (1992) Amplitude smoothing and phase shifting effect of the isolated perfused rat liver on oscillating insulin and glucagon. Horm Metab Res 24: 345–346
Holst JJ (1983) Glucagon in obesity. In: Lefèbvre PJ (ed) Glucagon II. Springer, Berlin Heidelberg New York, pp 507–521 (Handbook of experimental pharmacology, vol 66/II)
Holst JJ, Schwartz TW, Lovgreen NA, Pedersen O, Beck-Nielsen H (1983) Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity. Int J Obes 7: 529–538
Howes GA, Forbes JM (1987) A role for the liver in the effects of glucagon on food intake in domestic fowl. Physiol Behav 39: 587–592
Ishida R, Field JB (1983) Hepatic handling of glucagon. In: Lefèbvre PJ (ed) Glucagon II. Springer, Berlin Heidelberg New York, pp 361–388 (Handbook of experimental pharmacology, vol 66/II)
Johnson PR, Greenwood MRC, Horwitz BA, Stern JS (1991) Animal models of obesity: genetic aspects. Annu Rev Nutr 11: 325–353
Kalogeris TJ, Reidelberger RD, Mendel VE, Solomon TE (1991) Interaction of cholecystokinin-8 and pancreatic glucagon in control of food intake in dogs. Am J Physiol 260: R688–R692
Langhans W, Scharrer E (1987) Evidence for a role of the sodium pump of hepatocytes in the control of food intake. J Auton Nery Syst 20: 199–205
Langhans W, Scharrer E (1992) Metabolic control of eating, energy expenditure and the bioenergetics of obesity. In: Simopoulos AP (ed) World review of nutrition and dietetics. Karger, Basel, pp 1–67
Langhans W, Geary N, Scharrer N (1982a) Liver glycogen content decreases during meals in rats. Am J Physiol 243: R450–R453
Langhans W, Zieger U, Scharrer E, Geary N (1982b) Stimulation of feeding in rats by intraperitoneal injection of antibodies to glucagon. Science 218: 894–896
Langhans W, Pantel K, Muller-Schell W, Eggengerger E, Scharrer E (1984) Hepatic handling of pancreatic glucagon and glucose during meals in rats. Am J Physiol 247: R827–R832
Langhans W, Duss M, Scharrer E (1987) Decreased feeding and supraphysiological plasma levels of glucagon after glucagon injection in rats. Physiol Behav 41: 31–35
Le Sauter J, Geary N (1991) Hepatic portal glucagon infusion decreases spontaneous meal size in rats. Am J physiol 261: R154–R161
Le Sauter J, Geary N (1993) Le glucagon pancréatique: signal physiologique de la satiété post prandiale. Ann Endocrinol 54: 149–161
Le Sauter J, Noh U, Geary N (1991) Hepatic portal infusion of glucagon antibodies increases spontaneous meal size in rats. Am J Physiol 261: R162–R165
Lee JA, Ahmed Q, Burt AD (1992) Disappearance of hepatic parenchymal nerves in human liver cirrhosis. Gut 33: 87–91
Levine S, Sievert CE, Morley JE, Gosnell BA, Silvis SE (1984) Peptidergic regulation of feeding in the dog (Canis familiaris). Peptides 5: 675–679
Maclssac L, Geary N (1985) Partial liver denervations dissociate the inhibitory effects of pancreatic glucagon and epinephrine on feeding. Physiol Behav 35: 233–237
Madsen OD, Karlsen C, Blume N, Jensen HI, Larsson L-I, Holst JJ (1995) Transplantable glucagonomas derived from pluripotent rat islet tumor tissue cause severe anorexia and adipsia. Scand J Clin Lab Invest 55 [Suppl 220]: 27–36
Martin JR, Novin D (1977) Decreased feeding in rats following hepatic-portal infusion of glucagon. Physiol Behav 19: 461–466
Martin JR, Novin D, VanderWeele DA (1978) Loss of glucagon suppression of feeding after vagotomy in rats. Am J Physiol 234: E314–E318
McHugh P, Moran T, Barton GN (1975) A graded behavioral phenomenon regulating caloric intake. Science 190: 167–169
McLaughlin CL, Gingerich RL, Baffle CA (1986) Role of glucagon in the control of food intake in Zucker obese and lean rats. Brain Res Bull 17: 419–426
Miesner J, Smith GP, Gibbs J, Tyrka A (1992) Intravenous infusion of CCKA-receptor antagonist increases food intake in rats. Am J Physiol 262: R216–R219
Muller WA, Faloona GR, Aguilar-Parada E, Unger RH (1970) Abnormal alpha-cell function in diabetes. N Engl J Med 283: 109–115
Nilsson G, Uvnas-Wallenstein K (1977) Effect of teasing and sham feeding on plasma glucagon concentration in dogs. Acta Physiol Scand 100: 298–302
Palmer JP, Porte D Jr (1983) Neural control of glucagon secretion. In: Lefèbvre PJ (ed) Glucagon II. Springer, Berlin Heidelberg New York, pp 115–132 (Handbook of experimental pharmacology, vol 66/II)
Penick SB, Hinkle LE Jr (1961) Depression of food intake induced in healthy subjects by glucagon. N Engl J Med 264: 893–897
Polonsky KS, Jaspan JB, Rubenstein AH (1983) The metabolic clearance rate of glucagon. In: Lefèbvre PJ (ed) Glucagon II. Springer, Berlin Heidelberg New York, pp 353–359 (Handbook of experimental pharmacology, vol 66/11)
Prechtl JC, Powley TL (1987) A light and electron microscopic examination of the vagal hepatic branch of the rat. Anat Embryol (Berl) 176: 115–126
Ritter S, Weatherford SC (1986) Capsaicin pretreatment blocks glucagon-induced suppression of food intake. Appetite 7: 291
Ritter S, Weatherford SC, Stone SL (1986) Glucagon-induced inhibition of feeding is impaired by hepatic portal alloxan injection. Am J Physiol 250: R682–R690
Sawchenko PE, Friedman MI (1979) Sensory functions of the liver — a review. Am J Physiol 236: R5–R20
Scharrer E, Langhans W (1988) Metabolic and hormonal factors controlling food intake. Int J Vit Nutr Res 58: 249–261
Schulman JL, Carleton JL, Whitney G, Whitehorn JC (1957) Effect of glucagon on food intake and body weight in man. J Appl Physiol 11: 419–421
Seifter S, Englard S (1993) Energy metabolism. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA (eds) The liver: biology and pathobiology. Raven, New York, pp 279–315
Smith CJV, Bright-Taylor B (1974) Does a glucostatic mechanism for food intake control exist in chickens? Poultry Sci 53: 1720–1724
Smith GP, Gibbs J (1992) The development and proof of the CCK hypothesis of satiety. In: Dourish CT, Cooper SJ, Iversen SD, Iversen LL (eds) Multiple cholecystokinin receptors in the CNS. Oxford University Press, Oxford, pp 166–182
Stockinger Z, Geary N (1989) Pancreatic glucagon does not alter intrameal gastric emptying of milk in the rat. Physiol Behav 45: 1259–1261
Strubbe JH, Wolsink JG, Schutte AM, Prins AJA (1989) Hepatic-portal and cardiac infusion of CCK-8 and glucagon induce different effects on feeding. Physiol Behav 46: 643–646
Stunkard AJ, Van Itallie TB, Reis BB (1955) The mechanism of satiety: effect of glucagon on gastric hunger contractions in man. Proc Soc Exp Biol Med 89: 258–261
Taborsky GJ Jr (1989) The endocrine pancreas: control of secretion. In: Patton HD, Fuchs AF, Hille B, Scher AM, Steiner R (eds) Textbook of physiology, 21st edn. Saunders, Philadelphia, pp 1522–1543
VanderWeele DA, Geiselman PJ, Novin D (1979) Pancreatic glucagon, food deprivation and feeding in intact and vagotomized rabbits. Physiol Behav 23: 155–158
Wallace B, Lasker J (1993) Stand and deliver: getting peptide drugs into the body. Science 260: 912–915
Weatherford SC, Ritter S (1986) Glucagon satiety: diurnal variation after hepatic branch vagotomy or intraportal alloxan. Br Res Bull 17: 545–549
Weatherford SC, Ritter S (1988) Lesion of vagal afferent terminals impairs glucagoninduced suppression of food intake. Physiol Behav 43: 645–650
Weick BG, Ritter S (1986a) Dose-related suppression of feeding by intraportal glucagon infusion in the rat. Am J Physiol 250: R676–R681
Weick BG, Ritter S (1986b) Stimulation of insulin release and suppression of feeding by hepatic portal glucagon. Physiol Behav 38: 531–536
Weigle DS (1987) Pulsatile secretion of fuel-regulatory hormones. Diabetes 36: 764–775
Wynick D, Hammond P, Bloom S (1993) The glucagonoma syndrome. Clin Dermatol 11: 93–97
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Geary, N. (1996). Glucagon and the Control of Appetite. In: Lefèbvre, P.J. (eds) Glucagon III. Handbook of Experimental Pharmacology, vol 123. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61150-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-61150-6_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64718-5
Online ISBN: 978-3-642-61150-6
eBook Packages: Springer Book Archive